Royce Global Trust, Inc. filings document proxy and governance disclosures for a closed-end fund with stockholders and NYSE-listed common stock. Its Schedule 14A materials cover annual meeting notices, voting procedures, registrant-filed proxy status and matters presented to stockholders.
The filing record is centered on fund governance rather than operating-company segment reporting, with disclosures tied to stockholder rights and the formal meeting process for the Fund.
RGT submitted an annual Form N-CEN report providing registrant and fund governance details and operational responses for the reporting period. The filing lists aggregate brokerage commissions of $32,706.53 and reports principal transactions with a total value of $1,088,139,674.49.
The report consists mainly of standardized N-CEN fields—registrant background, directors, officers, custodians, service providers, securities lending, and broker and dealer disclosures—with many specific identification fields left blank in the provided excerpt.
Royce Global Trust, Inc. filed its Form N-CSR certified shareholder report covering the period January 1, 2025 through December 31, 2025. The annual review shows the Fund’s NAV total return of 23.22% for 2025 and a market price total return of 24.1%. Net assets were $100,012,174 with NAV per share of $15.24 and market price $13.11. The report includes detailed manager discussions for Royce Global Trust, Royce Micro-Cap Trust, and Royce Small-Cap Trust, schedules of investments, financial statements, disclosures on valuation and repurchase agreements, and litigation developments related to the MCSAA litigation now pending before the U.S. Supreme Court.
Raymond James & Associates, an investment adviser, filed an amended Schedule 13G reporting beneficial ownership of 166,794.17 shares of Royce Global Trust, Inc. common stock, representing 2.7% of the class as of the reported date. The firm reports no sole or shared voting power over these shares, but sole dispositive power over the full amount.
Raymond James states that the securities were acquired and are held in the ordinary course of business and not with the purpose or effect of changing or influencing control of Royce Global Trust, nor in connection with any such transaction other than activities solely in connection with a nomination under the specified proxy rule.
Royce Global Trust, Inc. (RGT) reported insider transactions on Form 4. A reporting person classified as “Other — Sr. Advisor Royce & Associates” disclosed three open-market sales of common stock held indirectly through a family investment entity: 36,075 shares at $12.49 on 11/10/2025, 65,266 shares at $12.52 on 11/11/2025, and 29,663 shares at $12.54 on 11/12/2025.
Following these transactions, the filing shows 549,346 shares indirectly held via the family investment entity. Separately, 122,881 shares are held indirectly in the Royce Charitable Trust. The footnote states the reporting person has a substantial pecuniary interest in the family entity and disclaims beneficial ownership of portions in which there is no pecuniary interest.
Royce Global Trust (RGT) reported insider transactions involving open‑market sales of common stock. The reporting person, identified as “Other — Sr. Advisor Royce & Associates,” sold 8,031 shares at $12.59 on 11/06/2025 and 2,533 shares at $12.44 on 11/07/2025. Following these sales, 680,350 shares were beneficially owned indirectly through a family investment entity. An additional 122,881 shares were reported as held indirectly in the Royce Charitable Trust.
ROYCE GLOBAL TRUST (RGT) reported a Form 4 for a reporting person listed as “Other — Sr. Advisor Royce & Associates.” On 11/05/2025, the person reported a sale of 8,432 shares of Common Stock at $12.61 per share, coded “S.”
Following the transaction, the filing shows 690,914 shares beneficially owned indirectly through a family investment entity and 122,881 shares indirectly held in the Royce Charitable Trust. The footnote states the person is the sole managing member of the family entity and disclaims beneficial ownership of portions in which there is no pecuniary interest.
Raymond James & Associates filed Amendment No. 9 to Schedule 13G, reporting beneficial ownership in Royce Global Trust, Inc. (RGT) following an event dated September 30, 2025.
The firm reports 336,858.95 shares beneficially owned, representing 5.4% of the class. It reports sole dispositive power over 336,858.95 shares and no voting power (sole or shared). Raymond James & Associates is identified as an investment adviser (IA) filer under Rule 13d-1(b), and certifies the securities were acquired and are held in the ordinary course, not for the purpose of influencing control.
Royce Global Trust insider filing: Christopher D. Clark, a director and President/CEO Investment Advisor, reported a purchase of 1,600 shares of Royce Global Trust at $12.69 per share on 08/26/2025. After the transaction he beneficially owned 50,638 shares directly and 5,000 shares indirectly (held by spouse). The Form 4 discloses no derivative transactions.
Royce Global Trust, Inc. files a definitive proxy outlining its board nominees and the Audit Committee charter. The proxy solicits votes to elect two director nominees, Patricia W. Chadwick and Michael K. Shields, and authorizes proxies to vote on other routine matters. The document describes committee responsibilities: overseeing financial statement integrity, selecting and overseeing the independent auditors, pre-approving audit and permissible non-audit services, reviewing audit scope and findings, and maintaining procedures for confidential reporting of accounting concerns. The Audit Committee standards require independence and at least one member with accounting or financial management expertise.